Literature DB >> 25232205

Adenocarcinoma of esophagogastric junction.

Jing-Yu Deng1, Han Liang1.   

Abstract

Entities:  

Year:  2014        PMID： 25232205      PMCID： PMC4153928          DOI： 10.3978/j.issn.1000-9604.2014.07.03

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  12 in total

Review 1.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

2.  Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction.

Authors:  Xiu-Feng Chen; Bo Zhang; Zhi-Xin Chen; Jian-Kun Hu; Bin Dai; Fang Wang; Hong-Xin Yang; Jia-Ping Chen
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

3.  Risk factors associated with early recurrence of adenocarcinoma of gastroesophageal junction after curative resection.

Authors:  Guodong Wang; Aiwen Wu; Xiaojing Cheng; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

4.  HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.

Authors:  Pamela L Kunz; Amirkaveh Mojtahed; George A Fisher; James M Ford; Daniel T Chang; Raymond R Balise; Charles D Bangs; Athena M Cherry; Reetesh K Pai
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-01

5.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

6.  Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.

Authors:  Ji-Gang Bai; Yi Lv; Cheng-Xue Dang
Journal:  Jpn J Clin Oncol       Date:  2006-06-09       Impact factor: 3.019

Review 7.  Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.

Authors:  J Rüdiger Siewert; Marcus Feith; Hubert J Stein
Journal:  J Surg Oncol       Date:  2005-06-01       Impact factor: 3.454

8.  Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study.

Authors:  Xiao-Dong Zhang; Yong-Qian Shu; Jun Liang; Feng-Chun Zhang; Xue-Zhen Ma; Jian-Jin Huang; Li Chen; Gen-Ming Shi; Wei-Guo Cao; Cheng-Ye Guo; Lin Shen; Mao-Lin Jin
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

9.  Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.

Authors:  Wen-Liang Fang; Chew-Wun Wu; Jen-Hao Chen; Su-Shin Lo; Mao-Chih Hsieh; King-Han Shen; Wen-Hu Hsu; Anna Fen-Yau Li; Wing-Yiu Lui
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

10.  Lymphadenectomy for gastric adenocarcinoma: should west meet east?

Authors:  Sam S Yoon; Han-Kwang Yang
Journal:  Oncologist       Date:  2009-09-08
View more
  6 in total

Review 1.  Gastro-esophageal junction cancers: what is the best minimally invasive approach?

Authors:  Egle Jezerskyte; Mark I van Berge Henegouwen; Miguel A Cuesta; Suzanne S Gisbertz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  "Sandwich Therapy"-Immunotherapy Plus Concurrent Chemoradiotherapy for Advanced Esophagogastric Junction Carcinoma: Report of Two Cases and Literature Review.

Authors:  Lei Wu; Juan Liu; Long Liang; Mian Mao; Xiangpan Li; Tao Li; Jinyi Lang; Qifeng Wang
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

3.  Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.

Authors:  Qifan Yin; Wenhao Wang; Huining Liu; Guang Yang; Shaohui Zhou; Lijun Liu
Journal:  J Cardiothorac Surg       Date:  2019-11-27       Impact factor: 1.637

4.  Surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction: transthoracic or transabdominal? -a single-center retrospective study.

Authors:  Zi-Feng Yang; De-Qing Wu; Jun-Jiang Wang; Xing-Yu Feng; Jia-Bin Zheng; Wei-Xian Hu; Yong Li
Journal:  Ann Transl Med       Date:  2018-12

5.  Microdissection of Human Esophagogastric Junction Wall with Phase-contrast X-ray CT Imaging.

Authors:  Jianfa Zhang; Guangzhao Zhou; Dongping Tian; Runhua Lin; Guanyun Peng; Min Su
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

6.  Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry.

Authors:  Kaixuan Zhu; Yingying Xu; Jiaxin Fu; Farah Abdidahir Mohamud; Zongkui Duan; Siyuan Tan; Zekun Zhao; Ping Chen; Liang Zong
Journal:  Dis Markers       Date:  2019-12-31       Impact factor: 3.434
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.